Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.01820217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Beta Therapy in Patients With Fabry Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Psy23 - Agalsidase Alfa and Agalsidase Beta for Treatment of Fabry Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparison of the Effects of Agalsidase Alfa and Agalsidase Beta on Cultured Human Fabry Fibroblasts and Fabry Mice

Journal of Human Genetics
Genetics
2005English

Limited Effects of Long-Term Enzyme Replacement Therapy on the Cardiac Conduction System in Fabry Disease

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2018English

Clinical Course of Patients With Fabry Disease Who Were Switched From Agalsidase-Β to Agalsidase-Α

Genetics in Medicine
MedicineGenetics
2014English

Dose-Dependent Effects of Iron Supplementation on Short-Term and Long-Term Memory in Adult Male Wistar Rats

Journal of Biological Sciences
Molecular MedicineCell Biology
2010English

Long-Term Effects of Aldosterone Blockade in Resistant Hypertension Associated With Chronic Kidney Disease

Journal of Human Hypertension
Internal Medicine
2011English

Biventricular Cardiomyopathy Improvement by Shifting Therapy From Agalsidase Alfa to Agalsidase Beta in Anderson-Fabry Disease (RCD Code: III-3B.2)

Journal of Rare Cardiovascular Diseases
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy